Skip to main content
OPTUS Pharmaceutical Co., Ltd. logo

OPTUS Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 131030 ISIN · KR7131030009 KO Manufacturing
Open in API
Filings indexed 159 across all filing types
Latest filing 2020-03-30 Audit Report / Informat…
Country KR South Korea
Listing KO 131030

About OPTUS Pharmaceutical Co., Ltd.

http://optuspharm.com/us/main/index.php

OPTUS Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, manufacturing, and commercialization of ophthalmic products. The company's primary expertise lies in producing sterile, preservative-free, single-dose (unit-dose) formulations. Its therapeutic portfolio addresses conditions such as dry eye syndrome, keratoconjunctival epithelial disease, bacterial conjunctivitis, and glaucoma. In addition to prescription and over-the-counter pharmaceuticals, the company is expanding into a total eye care model through its OUE& brand, which encompasses nutritional supplements (OUEFIT) and cosmeceuticals (OUELAB). The company operates EU-GMP certified manufacturing facilities and distributes its products globally.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Audit Report / Information Classification · 99% confidence The document is a comprehensive 'Audit Report' (감사보고서) for DHP Korea, covering the fiscal year 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the broader business activity report, and it is not an announcement (RPA) because it contains the full financial data. FY 2019
2020-03-30 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from DHP Korea regarding a decision to acquire treasury shares (자기주식 취득 결정). This is a formal regulatory filing in South Korea that details the company's plan to buy back its own shares for stock price stabilization and shareholder value enhancement. According to the provided definitions, a report of a company buying back its own shares is classified as 'Transaction in Own Shares' (POS).
2020-03-23 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, dividend declaration, director/auditor appointments, and compensation limits) held on 2020-03-11. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2020-03-11 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from DHP Korea. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, revenue, profit) for the fiscal year. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report to the regulator, rather than the full annual report document itself. Therefore, it is classified as a regulatory filing. FY 2019
2020-02-25 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for DHP Korea. It outlines the meeting date, location, agenda items (such as approval of financial statements, election of auditors, and director remuneration), and provides detailed management information and business reports required for shareholder review prior to the meeting. This document is a standard proxy statement/notice package sent to shareholders to solicit votes and provide information for the upcoming Annual General Meeting.
2020-02-24 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (참고서류) filed by DHP Korea. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, proxy solicitation details, and financial statements (balance sheet, income statement, and profit appropriation plan) for the fiscal year 2019. The document is structured to provide shareholders with the necessary information to exercise their voting rights at the meeting scheduled for March 11, 2020. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-02-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.